Eduardo Hallak, partner, will join the LSLS – Life Sciences Legal Strategy 2026, held on October 13–14 in Frankfurt, Germany. Mr. Hallak will feature as a speaker on the panel “Second Medical Use and Skinny Labelling: Building a Robust IP and Exclusivity Strategy.” The forum, dedicated to legal strategy in the life sciences sector, will bring together professionals to discuss intellectual property, regulation, competition, and corporate law, as well as trends and strategic challenges for companies in the industry.

Learn more at: https://lsstrategysummit.com/